Topic: regenerative medicine
The National Eye Institute's stem cell-based therapy safely prevented blindness in animal models of age-related macular degeneration.
The Harvard researcher who first discovered the "exercise hormone" irisin reports it may be useful in bone formation.
The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
The series D positions ViaCyte to generate phase 1/2 data on one candidate while working to get another back into the clinic.
MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.
BioCardia birngs on Mark Schwartz to be its vice president of clinical affairs as it moves forward with a phase 3 trial of its cell therapy.
United Therapeutics signed on to a collaboration with Israel-based CollPlant for the development of 3D-printed lung transplants.
An antisense technology for silencing genes that contribute to hampered insulin production may help treat Type 2 diabetes.
Researchers accidentally reprogrammed mature neurons into dopamine-producing neurons—a discovery that could spark new therapies for brain diseases.